tiprankstipranks
Advertisement
Advertisement
Biogen appoints Michael Parini as chief legal officer
PremiumThe FlyBiogen appoints Michael Parini as chief legal officer
8d ago
Biogen: CELIA Phase 2 Data Underpin Continued Confidence in Diranersen; Buy Rating and $256 Price Target Reiterated
Premium
Ratings
Biogen: CELIA Phase 2 Data Underpin Continued Confidence in Diranersen; Buy Rating and $256 Price Target Reiterated
8d ago
Biogen: CELIA Trial Data Reinforce Tau Leadership, Support Buy Rating and Unchanged $237 Price Target
Premium
Ratings
Biogen: CELIA Trial Data Reinforce Tau Leadership, Support Buy Rating and Unchanged $237 Price Target
8d ago
Biogen announces expanded data from CELIA study evaluating diranersen
PremiumThe FlyBiogen announces expanded data from CELIA study evaluating diranersen
9d ago
Ionis says Biogen presents Phase 2 CELIA data at AAIC
Premium
The Fly
Ionis says Biogen presents Phase 2 CELIA data at AAIC
9d ago
IQLIK Approval Seen as Commercial Enhancer, Not Fundamental Shift, as Biogen Neutral Rating and $200 Price Target Remain Unchanged
Premium
Ratings
IQLIK Approval Seen as Commercial Enhancer, Not Fundamental Shift, as Biogen Neutral Rating and $200 Price Target Remain Unchanged
9d ago
Biogen price target raised to $201 from $196 at Wedbush
PremiumThe FlyBiogen price target raised to $201 from $196 at Wedbush
10d ago
Biogen Maintained at Hold as Analyst Keeps $217 Price Target Amid Alzheimer’s Pipeline Uncertainty
Premium
Ratings
Biogen Maintained at Hold as Analyst Keeps $217 Price Target Amid Alzheimer’s Pipeline Uncertainty
10d ago
Biogen upgraded to Buy at Truist ahead of next week’s AAIC conference
Premium
The Fly
Biogen upgraded to Buy at Truist ahead of next week’s AAIC conference
10d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100